TAKEDA PHARMACEUTICAL CO LTD - 08 Dec 2025 SCHEDULE 13G/A Report for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID)

Filing Manager
TAKEDA PHARMACEUTICAL CO LTD
Reporting Manager
Takeda Pharmaceutical Company Limited
Security
Ovid Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol
OVID
Shares outstanding
71,398,341 shares
Disclosed Ownership
8,781,996 shares
Ownership
12.3%
Form type
SCHEDULE 13G/A
Filing time
09 Dec 2025, 21:02:19 UTC
Date of event
08 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Takeda Pharmaceutical Company Limited 12.3% 8,781,996 1,781,996 7,000,000 /s/ Max Heuer Max Heuer / Authorized Signatory
Takeda Pharmaceutical U.S.A., Inc. 9.8% 7,000,000 0 7,000,000 /s/ Paul Sundberg Paul Sundberg / Assistant Secretary